Cargando…

Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU

To evaluate sedation practices following a dexmedetomidine guideline update in the ICU. DESIGN: Single-center, retrospective chart review. SETTING: Tertiary academic medical center. PATIENTS: Patients were included in this analysis if they were admitted to the ICU and were ordered for continuous inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuler, Brian R., Kovacevic, Mary P., Dube, Kevin M., Szumita, Paul M., DeGrado, Jeremy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188421/
https://www.ncbi.nlm.nih.gov/pubmed/32426742
http://dx.doi.org/10.1097/CCE.0000000000000100
_version_ 1783527309399031808
author Schuler, Brian R.
Kovacevic, Mary P.
Dube, Kevin M.
Szumita, Paul M.
DeGrado, Jeremy R.
author_facet Schuler, Brian R.
Kovacevic, Mary P.
Dube, Kevin M.
Szumita, Paul M.
DeGrado, Jeremy R.
author_sort Schuler, Brian R.
collection PubMed
description To evaluate sedation practices following a dexmedetomidine guideline update in the ICU. DESIGN: Single-center, retrospective chart review. SETTING: Tertiary academic medical center. PATIENTS: Patients were included in this analysis if they were admitted to the ICU and were ordered for continuous infusion sedatives or opioids from September to November 2016 (PRE) and from September to November 2017 (POST). Patients were excluded from this analysis if they met any of the following criteria: mechanical ventilation less than 12 hours, admitted with acute neurologic injury, burn of greater than 20% total body surface area, chronic tracheostomy, admitted to the neuroscience or cardiac surgery ICU, on extracorporeal membrane oxygenation support, or received an infusion of neuromuscular blockers. INTERVENTIONS: Patients admitted during a restricted dexmedetomidine prescribing guideline were compared with patients admitted during an expanded prescribing guideline. MEASUREMENTS AND MAIN RESULTS: Of the 1,426 patients evaluated for inclusion, 427 patients met the criteria in this analysis. Of these, 217 patients were in the PRE and 210 patients in the POST. A majority of patients were excluded for admission to neuroscience or cardiac surgery ICU. Dexmedetomidine was used in 13.8% of encounters in the PRE and 51.9% of encounters in the POST (p < 0.001). The median duration of mechanical ventilation was 49 hours (24–110 hr) in the PRE and 47.5 hours (26–98 hr) in the POST (p = 0.8). ICU length of stay was a median of 136 and 121 hours in the PRE and POST, respectively (p = 0.2). The median hospital length of stay was 296 and 326 hours in the PRE and POST, respectively (p = 0.35). After controlling for possible confounders, ventilation time remained unchanged between the PRE and POST (p = 0.98). CONCLUSIONS: The expansion of a hospital dexmedetomidine prescribing guideline resulted in an increased use of dexmedetomidine but was not associated with a difference in length of mechanical ventilation.
format Online
Article
Text
id pubmed-7188421
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-71884212020-05-19 Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU Schuler, Brian R. Kovacevic, Mary P. Dube, Kevin M. Szumita, Paul M. DeGrado, Jeremy R. Crit Care Explor Original Clinical Report To evaluate sedation practices following a dexmedetomidine guideline update in the ICU. DESIGN: Single-center, retrospective chart review. SETTING: Tertiary academic medical center. PATIENTS: Patients were included in this analysis if they were admitted to the ICU and were ordered for continuous infusion sedatives or opioids from September to November 2016 (PRE) and from September to November 2017 (POST). Patients were excluded from this analysis if they met any of the following criteria: mechanical ventilation less than 12 hours, admitted with acute neurologic injury, burn of greater than 20% total body surface area, chronic tracheostomy, admitted to the neuroscience or cardiac surgery ICU, on extracorporeal membrane oxygenation support, or received an infusion of neuromuscular blockers. INTERVENTIONS: Patients admitted during a restricted dexmedetomidine prescribing guideline were compared with patients admitted during an expanded prescribing guideline. MEASUREMENTS AND MAIN RESULTS: Of the 1,426 patients evaluated for inclusion, 427 patients met the criteria in this analysis. Of these, 217 patients were in the PRE and 210 patients in the POST. A majority of patients were excluded for admission to neuroscience or cardiac surgery ICU. Dexmedetomidine was used in 13.8% of encounters in the PRE and 51.9% of encounters in the POST (p < 0.001). The median duration of mechanical ventilation was 49 hours (24–110 hr) in the PRE and 47.5 hours (26–98 hr) in the POST (p = 0.8). ICU length of stay was a median of 136 and 121 hours in the PRE and POST, respectively (p = 0.2). The median hospital length of stay was 296 and 326 hours in the PRE and POST, respectively (p = 0.35). After controlling for possible confounders, ventilation time remained unchanged between the PRE and POST (p = 0.98). CONCLUSIONS: The expansion of a hospital dexmedetomidine prescribing guideline resulted in an increased use of dexmedetomidine but was not associated with a difference in length of mechanical ventilation. Wolters Kluwer Health 2020-04-29 /pmc/articles/PMC7188421/ /pubmed/32426742 http://dx.doi.org/10.1097/CCE.0000000000000100 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Clinical Report
Schuler, Brian R.
Kovacevic, Mary P.
Dube, Kevin M.
Szumita, Paul M.
DeGrado, Jeremy R.
Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title_full Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title_fullStr Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title_full_unstemmed Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title_short Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
title_sort evaluation of sedation outcomes following increased dexmedetomidine use in the icu
topic Original Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188421/
https://www.ncbi.nlm.nih.gov/pubmed/32426742
http://dx.doi.org/10.1097/CCE.0000000000000100
work_keys_str_mv AT schulerbrianr evaluationofsedationoutcomesfollowingincreaseddexmedetomidineuseintheicu
AT kovacevicmaryp evaluationofsedationoutcomesfollowingincreaseddexmedetomidineuseintheicu
AT dubekevinm evaluationofsedationoutcomesfollowingincreaseddexmedetomidineuseintheicu
AT szumitapaulm evaluationofsedationoutcomesfollowingincreaseddexmedetomidineuseintheicu
AT degradojeremyr evaluationofsedationoutcomesfollowingincreaseddexmedetomidineuseintheicu